Bài báo khoa học Tập 65 Số CĐ 3 - Bệnh viện Phổi Trung ương 15/05/2024

5. THỰC TRẠNG TRẦM CẢM THEO THANG ĐIỂM PHQ-9 Ở NGƯỜI BỆNH LAO KHÁNG THUỐC TẠI VIỆT NAM NĂM 2023

Lê Ngọc Huy1,2, Nguyễn Bình Hòa1,2, Lê Minh Giang3,4, Nguyễn Huy Bình3,4, Đinh Văn Lượng1,2
1 National Lung Hospital
2 Bệnh viện Phổi Trung ương
3 Hanoi Medical University
4 Đại học Y Hà Nội
Tác giả liên hệ: Huy.lengochmu@gmail.com
DOI: 10.52163/yhc.v65iCD3.1100
22 Lượt xem
14 Lượt tải xuống
Từ khóa
Lao kháng thuốc, trầm cảm, tuân thủ điều trị.
Tóm tắt

Tổng quan: Trầm cảm là vấn đề nghiêm trọng trong quản lý và điều trị lao kháng thuốc. Trầm cảm làm tăng nguy cơ thất bại điều trị, kháng thuốc và nguy cơ tử vong. Thang điểm PHQ-9 là thang điểm được sử dụng rộng rãi trong đánh giá mức độ trầm cảm. Nghiên cứu này nhằm đánh giá mức độ trầm cảm và các yếu tố liên quan ở người bệnh lao kháng thuốc tại Việt Nam.

Phương pháp: Nghiên cứu này áp dụng phương pháp định lượng qua bảng câu hỏi và phân tích thống kê mô tả để xác định mức độ trầm cảm và các yếu tố liên quan.

Kết quả: Kết quả cho thấy 34.4% bệnh nhân không bị trầm cảm, trong khi đó có tới 36.8% bệnh nhân mắc trầm cảm nhẹ và 14% mắc trầm cảm trung bình. Mức độ trầm cảm tăng lên đáng kể ở những người từng quên uống thuốc lao (OR = 0,5; p = 0,032) và nhóm kiến thức kém với tỉ lệ trầm cảm cao (70,2%).

Thảo luận: Nghiên cứu nhấn mạnh tầm quan trọng của việc sàng lọc và can thiệp trầm cảm ở bệnh nhân lao kháng thuốc, đặc biệt là những người có lịch sử không tuân thủ điều trị. Việc tăng cường hỗ trợ tâm lý và can thiệp kịp thời có thể cải thiện chất lượng cuộc sống và kết quả điều trị lao

 

Tài liệu tham khảo
[1]
Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Google Scholar
[2]
Stockings E, Scott JG, et al. Global Epidemiology and Google Scholar
[3]
Burden of Schizophrenia: Findings Google Scholar
[4]
From the Global Burden of Disease Study 2016. Google Scholar
[5]
Schizophr Bull. 2018 Oct 17;44(6):1195–203. Google Scholar
[6]
Depression and Other Common Mental Disorders Google Scholar
[7]
[Internet]. [cited 2024 Apr 6]. Available Google Scholar
[8]
from: https://www.who.int/publications-detail- Google Scholar
[9]
redirect/depression-global-health-estimates Google Scholar
[10]
Global Tuberculosis Report 2023 [Internet]. [cited Google Scholar
[11]
Mar 13]. Available from: https://www. Google Scholar
[12]
who.int/teams/global-tuberculosis-programme/ Google Scholar
[13]
tb-reports/global-tuberculosis-report-2023 Google Scholar
[14]
Sweetland A, Oquendo M, Wickramaratne P, Google Scholar
[15]
Weissman M, Wainberg M. Depression: a silent Google Scholar
[16]
driver of the global tuberculosis epidemic. World Google Scholar
[17]
Psychiatry. 2014 Oct;13(3):325–6. Google Scholar
[18]
Vega P, Sweetland A, Acha J, Castillo H, Guerra Google Scholar
[19]
D, Smith Fawzi MC, et al. Psychiatric issues in Google Scholar
[20]
the management of patients with multidrug-resistant Google Scholar
[21]
tuberculosis. Int J Tuberc Lung Dis Off J Google Scholar
[22]
Int Union Tuberc Lung Dis. 2004 Jun;8(6):749–59. Google Scholar
[23]
Pachi A, Bratis D, Moussas G, Tselebis A. Psychiatric Google Scholar
[24]
Morbidity and Other Factors Affecting Google Scholar
[25]
Treatment Adherence in Pulmonary Tuberculosis Google Scholar
[26]
Patients. Tuberc Res Treat. 2013;2013:489865. Google Scholar
[27]
Redwood L, Mitchell EMH, Viney K, Snow K, Google Scholar
[28]
Nguyen TA, Dung LAT, et al. Depression, stigma and Google Scholar
[29]
quality of life in people with drug-susceptible TB Google Scholar
[30]
and drug-resistant TB in Vietnam.Int J Tuberc Lung Dis. Google Scholar
[31]
Jun 1;25(6):461–7. Google Scholar
[32]
Acha J, Sweetland A, Guerra D, Chalco K, Castillo Google Scholar
[33]
H, Palacios E. Psychosocial support groups for patients Google Scholar
[34]
with multidrug-resistant tuberculosis: five years of Google Scholar
[35]
experience. Glob Public Health. 2007;2(4):404–17. Google Scholar
[36]
Aydin IO, Uluşahin A. Depression, anxiety Google Scholar
[37]
comorbidity, and disability in tuberculosis and Google Scholar
[38]
chronic obstructive pulmonary disease patients: Google Scholar
[39]
applicability of GHQ-12. Gen Hosp Psychiatry. Google Scholar
[40]
;23(2):77–83. Google Scholar
[41]
Deribew A, Tesfaye M, Hailmichael Y, Apers Google Scholar
[42]
L, Abebe G, Duchateau L, et al. Common mental Google Scholar
[43]
disorders in TB/HIV co-infected patients in Google Scholar
[44]
Ethiopia. BMC Infect Dis. 2010 Jul 9;10:201. Google Scholar
[45]
Galea JT, Monedero-Recuero I, Sweetland AC. Google Scholar
[46]
Beyond screening: a call for the routine integration of Google Scholar
[47]
mental health care with tuberculosis treatment. Google Scholar
[48]
Public Health Action. 2019 Mar 21;9(1):2. Google Scholar
[49]
Where there’s a will, there’s a way: advancing Google Scholar
[50]
integrated care for mental health, substance Google Scholar
[51]
use and tuberculosis disease - PubMed [Internet]. Google Scholar
[52]
[cited 2024 Apr 6]. Available from: https:// Google Scholar
[53]
pubmed.ncbi.nlm.nih.gov/31097057/ Google Scholar
[54]
Van Rie A, Sengupta S, Pungrassami P, Balthip Google Scholar
[55]
Q, Choonuan S, Kasetjaroen Y, et al. Measuring Google Scholar
[56]
stigma associated with tuberculosis and HIV/ Google Scholar
[57]
AIDS in southern Thailand: exploratory and Google Scholar
[58]
confirmatory factor analyses of two new scales. Google Scholar
[59]
Trop Med Int Health TM IH. 2008 Jan;13(1):21– Google Scholar
[60]
Alonso J, Liu Z, Evans-Lacko S, Sadikova E, Google Scholar
[61]
Sampson N, Chatterji S, et al. Treatment gap for Google Scholar
[62]
anxiety disorders is global: Results of the World Google Scholar
[63]
Mental Health Surveys in 21 countries. Depress Google Scholar
[64]
Anxiety. 2018 Mar;35(3):195–208. Google Scholar
[65]
Kroenke K, Spitzer RL, Williams JB. The PHQ- Google Scholar
[66]
: validity of a brief depression severity measure. Google Scholar
[67]
J Gen Intern Med. 2001 Sep;16(9):606–13. Google Scholar
[68]
Ali GC, Ryan G, De Silva MJ. Validated Screening Google Scholar
[69]
Tools for Common Mental Disorders in Low Google Scholar
[70]
and Middle Income Countries: A Systematic Review. Google Scholar
[71]
PLoS ONE. 2016 Jun 16;11(6):e0156939. Google Scholar
[72]
Nguyen N, An P, Tien N. Reliability and Validity Google Scholar
[73]
of Vietnamese Version of Patient Health Questionnaire 9 Google Scholar
[74]
Items (PHQ-9) Among UMP Medical Freshmen. Google Scholar
[75]
In 2022. p. 901–23. Google Scholar
[76]
Lotrakul M, Sumrithe S, Saipanish R. Reliability Google Scholar
[77]
and validity of the Thai version of the PHQ-9. Google Scholar
[78]
BMC Psychiatry. 2008;8:46. Google Scholar
[79]
Kigozi G. Confirmatory factor analysis of the Google Scholar
[80]
Patient Health Questionnaire-9: A study amongst Google Scholar
[81]
tuberculosis patients in the Free State province. Google Scholar
[82]
South Afr J Infect Dis [Internet]. 2020 [cited Google Scholar
[83]
Apr 6];35(1). Available from: https://www. Google Scholar
[84]
ncbi.nlm.nih.gov/pmc/articles/PMC8378120/ Google Scholar
[85]
Velen K, Nguyen VN, Nguyen BH, Dang T, Google Scholar
[86]
Nguyen HA, Vu DH, et al. Harnessing new Google Scholar
[87]
mHealth technologies to Strengthen the Management Google Scholar
[88]
of Multidrug-Resistant Tuberculosis in Vietnam Google Scholar
[89]
(V-SMART trial): a protocol for a randomised Google Scholar
[90]
controlled trial. BMJ Open. 2022 Jun22;12(6):e052633. Google Scholar
[91]
The Patient Health Questionnaire (PHQ-9) as a Google Scholar
[92]
tool to screen for depression in people with multiple Google Scholar
[93]
sclerosis: a cross-sectional validation study Google Scholar
[94]
| BMC Psychology | Full Text [Internet]. [cited Google Scholar
[95]
Apr 6]. Available from: https://bmcpsychology. Google Scholar
[96]
biomedcentral.com/articles/10.1186/ s40359-022-00949-8 Google Scholar
[97]
Shrestha SK, Joshi S, Bhattarai RB, Joshi LR, Google Scholar
[98]
Adhikari N, Shrestha SK, et al. Prevalence Google Scholar
[99]
and risk factors of depression in patients with Google Scholar
[100]
drug-resistant tuberculosis in Nepal: A cross-sectional Google Scholar
[101]
study. J Clin Tuberc Mycobact Dis. 2020 Oct 29;21:100200. Google Scholar
[102]
Batte C, Namusobya MS, Kirabo R, Mukisa J, Google Scholar
[103]
Adakun S, Katamba A. Prevalence and factors Google Scholar
[104]
associated with non-adherence to multi-drug resistant Google Scholar
[105]
tuberculosis (MDR-TB) treatment at Mulago National Google Scholar
[106]
Referral Hospital, Kampala, Uganda. Afr Health Sci. Google Scholar
[107]
Apr 16;21(1):238–47. Google Scholar
[108]
Endo Y, Jaramillo J, Yadav RPH. Patient- and Google Scholar
[109]
Health-System-Related Barriers to Treatment Google Scholar
[110]
Adherence for Patients with Drug-Resistant Google Scholar
[111]
Tuberculosis in the Philippines: A Mixed-Methods Google Scholar
[112]
Study. Tuberc Res Treat. 2022 Nov 19;2022:e6466960. Google Scholar
[113]
Sharma R, Bakshi H, Prajapati S, Bhatt GS, Mehta R, Google Scholar
[114]
Rami KC, et al. Prevalence and Determinants of Google Scholar
[115]
Depression among Multi Drug Resistant Google Scholar
[116]
(MDR) TB cases registered under National Google Scholar
[117]
Tuberculosis Elimination Program in Ahmedabad Google Scholar
[118]
City. Indian J Community Med Off Publ Indian Google Scholar
[119]
Assoc Prev Soc Med. 2022;47(1):45–9. Google Scholar
[120]
Risk Factors for Depression in Tuberculosis Google Scholar
[121]
Patients: A Meta-Analysis - PMC [Internet]. [cited Google Scholar
[122]
Apr 6]. Available from: https://www.ncbi. Google Scholar
[123]
nlm.nih.gov/pmc/articles/PMC9012238/ Google Scholar